Analyst Ratings for Humacyte (HUMA)
HUMA Rating Summary
HUMA Price Target Summary
- Highest: $25.00 (D. Boral Capital)
- Lowest: $0.50 (Barclays)
- Average: $4.96
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.96 (+1054.5%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
Avg. $ Target:
$4.96 (+1054.5%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | Barclays | Matt Miksic | New Coverage | Equalweight (N/A) |
0.50 (N/A) |
0.50 (0.43) |
-14% | Details |
| 3/31/2026 | StoneX » Updated 10/16/2026 |
Bruce D. Jackson | Downgrade | Speculative Buy (Buy) |
1.00 (1.00) |
0.57 (0.43) |
-24.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
